Alexion Revenue AUGMENTED by New Soliris Users and 4 Stocks Soaring to 52-Week Highs

| + More Articles
  • Like on Facebook
  • Share on Google+
  • Share on LinkedIn

Alexion Pharmaceutic (NASDAQ:ALXN) revenues were further enhanced by an increasing number of new patients suffering from atypical hemolytic uremic syndrome starting the use of Soliris treatment, as well as by $3.3 million originating from shipments of Soliris that occurred in 2011. Shares closed up 7.69 percent on the day at $105.13, and have traded in a 52-week range of $46.56 to $104.38.

Don’t Miss: Sprint Earnings: DIALS Past Revenue Estimate, Shares RING Higher.

Aol Inc. (NYSE:AOL) posted second quarter revenue of $531.1 million, with a consensus of $519.36 million. Subscription revenue trends continued to move up significantly with a 12 percent decline in subscribers representing the lowest rate of decline in 5 years, while the monthly average churn of 1.7 percent was the lowest rate of churn in more than 10 years. Shares closed up 7.24 percent on the day at $29.48, having traded in a 52-week range of $10.06 to $28.97.

Lumber Liquidators (NYSE:LL) increases its fiscal year net sales estimate to between $750 million and $775 million, up from $720 million to $750 million, against a consensus of $755.46 million. The company sees same-store sales up in the mid-single digits, while it expects to open between 20 and 25 new store locations, which includes 2 to 4 in Canada. Shares closed up 26.8 percent on the day at $41.31, and have traded in a 52-week range of $13.43 to $34.71.

The Medicines Company (NASDAQ:MDCO) posted second quarter adjusted earnings per share of 46 cents, compared to a consensus of 17 cents. Shares closed up 12.19 percent at $25.67, having been traded in a 52-week range of $12.33 to $24.93.

Shares of Streamline Health Solutions, Inc. (NASDAQ:STRM) gain a tenth of their value on the news that the firm has entered into a five-year, software as a service licensing contract with the worldwide business advisory firm, FTI Consulting, Inc. (NYSE:FCN). The new license quickly follows a recently reported joint marketing deal between the two firms. To treat their clients’ revenue cycle challenges, FTI will employ Streamline Health’s OpportunityAnyWare business intelligence, analytics, and patient financial services automated workflow solutions for accounts receivable, denials, and audits. Shares closed up 10.79 percent at $3.80, and have traded in a 52-week range of $1.35 to $3.81.

Don’t Miss: Fed Chatter and Caterpillar Outlook LIFT Gold and Silver.

Want news like this in real-time so you can get an edge? Click here for Wall St. Cheat Sheet Pro.

More Articles About:

To contact the reporter on this story: staff.writers@wallstcheatsheet.com To contact the editor responsible for this story: editors@wallstcheatsheet.com

Yahoo Finance, Harvard Business Review, Market Watch, The Wall St. Journal, Financial Times, CNN Money, Fox Business